The heart valve specialist saw better-than-expected TAVR sales in the first quarter as hospitals addressed capacity ...

Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat ...

This week’s Bulls N’ Bears ASX Runner of the Week is… Redstone Resources, which announced a biblically deep drill hole to ...